Health News

A study published today in the New England Journal of Medicine reports a potential new investigational therapy for advanced and metastatic basal cell skin cancer tested at the Virginia G. Piper Cancer Center at Scottsdale Healthcare and other sites appears to demonstrate tumor shrinkage and limited side effects in patients.

Read more

Filed under: Pharmacy News
Tags: cancer, medicine, Pharmacy, skin cancer, Tumor

Related posts

• What Is Herceptin (trastuzumab)? What Is Herceptin For? (0)
  Herceptin is the brand name of a medicine called trastuzumab. This medicine can stop the growth of breast cancer and sometimes reduce the size of the tumor. Herceptin is given by a drip into a vein. It can be given in combination with chemotherapy, or on its own to patients who have already had [...]
  
  
• What Is Herceptin (trastuzumab)? What Is Herceptin For? (0)
  Herceptin is the brand name of a medicine called trastuzumab. This medicine can stop the growth of breast cancer and sometimes reduce the size of the tumor. Herceptin is given by a drip into a vein. It can be given in combination with chemotherapy, or on its own to patients who have already had [...]
  
  
• Topline, interim results from Celldex Phase 2b EMERGE study of CDX-011 for advanced breast cancer (0)
  Celldex Therapeutics, Inc. today announced that interim, topline results of the Phase 2b EMERGE study of CDX-011 in patients with advanced breast cancer will be presented in a webcast on May 23, 2012. Linda Vahdat, MD, Professor of Medicine, Chief of Solid Tumor Service and Director of the Breast Cancer Research Program at Weill Cornell [...]
  
  
• Thrombocytosis linked to severity of ovarian cancer (0)
  Highly elevated platelet levels fuel tumor growth and reduce the survival of ovarian cancer patients, an international team of researchers led by scientists at The University of Texas MD Anderson Cancer center reports in the New England Journal of Medicine. Read more [tags] Pharmacy News [/tags]
  
  
• Study compares adoptive T-cell therapy with drug-based cancer treatment (0)
  In the treatment of large tumors, how effective is adoptive T cell therapy in comparison to drug-based cancer treatment? To answer this question, Dr. Kathleen Anders and Professor Thomas Blankenstein of the Max Delbr-ck Center for Molecular Medicine (MDC) Berlin-Buch and researchers of the Beckman Research Institute of the City of Hope Cancer Center in [...]